Inhibition of KATP channel activity augments baroreflex-mediated vasoconstriction in exercising human skeletal muscle

Journal of Physiology

Volumn 561, Issue 1, 2004, Pages 273-282

  Keller, David Melvin ^a,b   Ogoh, Shigehiko ^a   Greene, Shane ^a   Olivencia Yurvati, A ^a   Raven, Peter B ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b Institute for Exercise and Environmental Medicine Dallas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); GLIBENCLAMIDE; POTASSIUM CHANNEL; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ADENOSINE TRIPHOSPHATE; ANTIARRHYTHMIC AGENT; POTASSIUM CHANNEL BLOCKING AGENT;

ADRENERGIC RECEPTOR BLOCKING; ADULT; ARTICLE; CAROTID SINUS PRESSORECEPTOR REFLEX; CONDUCTANCE; CONTROLLED STUDY; EXERCISE; FEMALE; HUMAN; HUMAN EXPERIMENT; KNEE; LEG BLOOD FLOW; LEG MOVEMENT; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REST; SKELETAL MUSCLE; SYMPATHETIC TONE; VASOCONSTRICTION; ADRENERGIC ACTIVITY; ELECTROPHYSIOLOGY; LEG BLOOD VESSEL; LEG EXERCISE; LEG VASCULAR CONDUCTANCE; MUSCLE CONTRACTION; PROTEIN DETERMINATION; PROTEIN FUNCTION; SYMPATHETIC FUNCTION; ADRENERGIC SYSTEM; CAROTID BODY; CLINICAL TRIAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; VASCULARIZATION;

ADENOSINE TRIPHOSPHATE; ADULT; ANTI-ARRHYTHMIA AGENTS; BAROREFLEX; CAROTID BODY; EXERCISE; FEMALE; GLYBURIDE; HUMANS; KNEE; MALE; MUSCLE, SKELETAL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; REST; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION;

EID: 9244231105     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.071993     Document Type: Article

References (38)

1. Banitt PF, Smits P, Williams SB, Ganz P & Creager MA (1996). Activation of ATP-sensitive potassium channels contributes to reactive hyperemia in humans. Am J Physiol 271, H1594-H1598.
2. Buckwalter JB & Clifford PS (1999). alpha-adrenergic vasoconstriction in active skeletal muscles during dynamic exercise. Am J Physiol 277, H33-H39.
3. Buckwalter JB, Naik JS, Valic Z & Clifford PS (2001). Exercise attenuates alpha-adrenergic-receptor responsiveness in skeletal muscle vasculature. J Appl Physiol 90, 172-178.
4. Buckwalter JB, Taylor JC, Hamann JJ & Clifford PS (2004). Role of nitric oxide in exercise sympatholysis. J Appl Physiol 97, 417-423; discussion 416.
5. Clark MG, Wallis MG, Barrett EJ, Vincent MA, Richards SM, Clerk LH et al. (2003). Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab 284, E241-E258.
6. Collins HL, Augustyniak RA, Ansorge EJ & O'Leary DS (2001). Carotid baroreflex pressor responses at rest and during exercise: cardiac output vs. regional vasoconstriction. Am J Physiol Heart Circ Physiol 280, H642-H648.
7. Dinenno FA & Joyner MJ (2003). Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: is nitric oxide obligatory? J Physiol 553, 281-292.
8. Fadel PJ, Ogoh S, Watenpaugh DE, Wasmund W, Olivencia-Yurvati A, Smith ML et al. (2001). Carotid baroreflex regulation of sympathetic nerve activity during dynamic exercise in humans. Am J Physiol Heart Circ Physiol 280, H1383-H1390.
9. + channels does not affect reactive hyperemia in human forearm. Am J Physiol Heart Circ Physiol 284, H711-H718.
10. Green D, Cheetham C, Reed C, Dembo L & O'Driscoll G (2002). Assessment of brachial artery blood flow across the cardiac cycle: retrograde flows during cycle ergometry. J Appl Physiol 93, 361-368.
11. Hansen J, Sander M, Hald CF, Victor RG & Thomas GD (2000a . Metabolic modulation of sympathetic vasoconstriction in human skeletal muscle: role of tissue hypoxia. J Physiol 527, 387-396.
12. Hansen J, Sander M & Thomas GD (2000b). Metabolic modulation of sympathetic vasoconstriction in exercising skeletal muscle. Acta Physiol Scand 168, 489-503.
13. Hoelting BD, Scheuermann BW & Barstow TJ (2001). Effect of contraction frequency on leg blood flow during knee extension exercise in humans. J Appl Physiol 91, 671-679.
14. Joyner MJ & Thomas GD (2003). Having it both ways? Vasoconstriction in contracting muscles. J Physiol 550, 333.
15. Keller D, Fadel PJ, Ogoh S, Brothers RM, Hawkins M, Olivencia-Yurvati & Raven PB (2004). Carotid baroreflex control of leg vasculature in exercising and non-exercising skeletal muscle in humans. J Physiol 561, 283-293.
16. Keller DM, Wasmund WL, Wray DW, Ogoh S, Fadel PJ, Smith ML et al. (2003). Carotid baroreflex control of leg vascular conductance at rest and during exercise. J Appl Physiol 94, 542-548.
17. Kent BB, Drane JW, Blumenstein B & Manning JW (1972). A mathematical model to assess changes in the baroreceptor reflex. Cardiology 57, 295-310.
18. Kosmas EN, Levy RD & Hussain SN (1995). Acute effects of glyburide on the regulation of peripheral blood flow in normal humans. Eur J Pharmacol 274, 193-199.
19. Lembo G, Iaccarino G, Rendina V, Volpe M & Trimarco B (1994). Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans. Hypertension 24, 429-438.
20. Nelson MT & Quayle JM (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268, C799-C822.
21. Ogoh S, Fadel PJ, Nissen P, Jans O, Selmer C, Secher NH et al. (2003). Baroreflex-mediated changes in cardiac output and vascular conductance in response to alterations in carotid sinus pressure during exercise in humans. J Physiol 550, 317-324.
22. O'Leary DS, Rowell LB & Scher AM (1991). Baroreflex-induced vasoconstriction in active skeletal muscle of conscious dogs. Am J Physiol 260, H37-H41.
23. Osada T & Radegran G (2002). Femoral artery inflow in relation to external and total work rate at different knee extensor contraction rates. J Appl Physiol 92, 1325-1330.
24. Potts JT, Shi XR & Raven PB (1993). Carotid baroreflex responsiveness during dynamic exercise in humans. Am J Physiol 265, H1928-H1938.
25. Quast U, Guillon JM & Cavero I (1994). Cellular pharmacology of potassium channel openers in vascular smooth muscle. Cardiovasc Res 28, 805-810.
26. Quayle JM & Standen NB (1994). KATP channels in vascular smooth muscle. Cardiovasc Res 28, 797-804.
27. Remensnyder JP, Mitchell JH & Sarnoff SJ (1962). Functional sympatholysis during muscular activity. Circ Res 11, 370-380.
28. Rosenmeier JB, Hansen J & Gonzalez-Alonso J (2004). Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 558, 351-365.
29. Ruble SB, Valic Z, Buckwalter JB, Tschakovsky ME & Clifford PS (2002). Attenuated vascular responsiveness to noradrenaline release during dynamic exercise in dogs. J Physiol 541, 637-644.
30. Saltin B (1985). Hemodynamic adaptations to exercise. Am J Cardiol 55, 42D-47D.
31. Thomas GD, Hansen J & Victor RG (1994). Inhibition of alpha 2-adrenergic vasoconstriction during contraction of glycolytic, not oxidative, rat hindlimb muscle. Am J Physiol 266, H920-H929.
32. Thomas GD, Hansen J & Victor RG (1997). ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest 99, 2602-2609.
33. Thomas GD & Victor RG (1998). Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol 506, 817-826.
34. Tschakovsky ME, Sujirattanawinol K, Ruble SB, Valic Z & Joyner MJ (2002). Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle? J Physiol 541, 623-635.
35. Wilson TE, Cui J & Crandall CG (2001). Absence of arterial baroreflex modulation of skin sympathetic activity and sweat rate during whole-body heating in humans. J Physiol 536, 615-623.
36. Wilson TE, Cui J & Crandall CG (2002). Effect of whole-body and local heating on cutaneous vasoconstrictor responses in humans. Auton Neurosci 97, 122-128.
37. Wray D, Fadel P, Keller D, Ogoh S, Sander M, Raven P et al. (2004a). Dynamic carotid baroreflex control of the peripheral circulation during exercise in humans. J Physiol 559, 675-684.
38. Wray DW, Fadel PJ, Smith ML, Raven P & Sander M (2004b . Inhibition of α-adrenergic vasoconstriction in exercising human thigh muscles. J Physiol 555, 545-563.